Smartkarma Newswire

Vistra Corp. (VST)

166.73 USD +5.92 (+3.68%) Volume: 9.57M

Vistra Corp.’s stock price is currently at a strong 166.73 USD, showcasing a promising increase of +3.68% this trading session. With a notable trading volume of 9.57M and a substantial YTD percentage change of +20.93%, VST’s stock performance continues to impress investors and outperform market expectations.

Latest developments on Vistra Corp.

In recent news, Vistra has been making headlines with its stock price movements. Despite some fluctuations, Vistra Energy stock managed to soar to an all-time high of $168.7, showcasing its strength in the market. However, there have been some dips in the stock price, with Vistra (NYSE:VST) experiencing a 0.5% and 1.4% decrease in its stock price. On the other hand, Constellation Energy saw a significant jump following a $26 billion deal, with analysts noting that they are becoming more like Vistra. With Vistra Corp. (VST) stock being a trending topic and the subject of speculation by hedge funds, investors are keeping a close eye on this utility stock for potential opportunities.

Vistra Corp. on Smartkarma

Analysts at Baptista Research on Smartkarma have published a bullish report on Vistra Corp, highlighting the company’s diversification of its energy portfolio as a key driver for growth. The report discusses Vistra Corp’s third-quarter 2024 results, which show a mix of achievements and challenges in line with the energy industry’s current dynamics. Despite milder weather conditions in Texas, the company reported a strong operational performance with an adjusted EBITDA of $1.444 billion, showcasing robust execution across its generation, commercial, and retail sectors.

A look at Vistra Corp. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Vistra has a positive long-term outlook. With high scores in Growth and Momentum, the company is positioned for future expansion and success. This indicates that Vistra is likely to experience strong growth in the coming years and maintain a positive market momentum.

Although Vistra has lower scores in Value, Dividend, and Resilience, the high scores in Growth and Momentum suggest that the company’s overall outlook remains optimistic. As a provider of utility services with a global customer base, Vistra Corp. is well-positioned to capitalize on opportunities for growth and innovation in the energy sector.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Zimmer Biomet Holdings, Inc. (ZBH)

104.54 USD +3.00 (+2.95%) Volume: 2.66M

Zimmer Biomet Holdings, Inc.’s stock price is currently at 104.54 USD, marking a positive shift of +2.95% this trading session with a trading volume of 2.66M. Despite a slight YTD decrease of -1.21%, ZBH continues to be a key player in the medical devices market.

Latest developments on Zimmer Biomet Holdings, Inc.

Today, Zimmer Biomet Holdings Inc. (NYSE:ZBH) experienced a mix of highs and lows in the stock market. Despite facing losses, the company’s stock outperformed competitors, showcasing its resilience in the market. However, Zimmer Biomet Holdings also set a new 12-month low, causing some concern among investors. This fluctuation in stock price may have been influenced by recent sell-offs, such as the 4,885 shares sold by ST Germain D J Co. Inc. and shares sold by Douglas Lane & Associates LLC. Investors will be closely monitoring the company’s performance in the coming days to see how it recovers from this dip.

A look at Zimmer Biomet Holdings, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Zimmer Biomet Holdings has a positive long-term outlook. With high scores in value and momentum, the company is positioned well for growth and potential returns for investors. While the resilience score is lower, Zimmer Biomet Holdings’ strong value and momentum scores indicate a promising future for the company.

Zimmer Biomet Holdings, Inc. is a company that designs, develops, manufactures, and markets medical equipment such as orthopedic, dental, and spinal reconstructive implants. With a focus on innovation and serving patients worldwide, Zimmer Biomet Holdings is positioned to continue its growth and success in the medical equipment industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

CVS Health Corporation (CVS)

48.01 USD +2.00 (+4.35%) Volume: 16.38M

CVS Health Corporation’s stock price surges to $48.01, marking a noteworthy increase of +4.35% this trading session with a robust trading volume of 16.38M shares. With a year-to-date percentage change of +6.95%, CVS’s stock continues its upward trend, showcasing strong performance in the market.

Latest developments on CVS Health Corporation

Today, CVS Health Corp stock experienced modest gains as Moon Capital Management liquidated their position with a modest gain. Market whales have been making recent bets on CVS options, contributing to the stock’s movement. Despite a slight decrease of 0.09%, CVS Health Corp stock outperformed competitors on a strong trading day. Douglas Lane & Associates LLC also lowered their position in CVS Health Co. However, CVS successfully converted commercial pharmacy contracts to a “cost plus” model, which may have contributed to its attractiveness with a safe yield of 5.8%. After a significant 40% fall in 2024, investors are now looking to see if CVS Health stock can turn things around this year.

CVS Health Corporation on Smartkarma

Analysts on Smartkarma have differing views on Cvs Health Corp. According to a report from Value Investors Club, the author suggests a potential 30%+ downside for CVS due to declining performance in its Pharmacy & Consumer Wellness operations. The author compares CVS’s situation to using bad grapes to make wine, indicating a terminal segment. They recommend pair trades such as going long on CI and short on CVS. On the other hand, Baptista Research presents a bullish perspective on CVS Health Corporation, highlighting its strategic leverage in Pharmacy Benefit Management (PBM) and Insurance Operations. Despite challenges in the Health Care Benefits segment, CVS saw revenues exceeding $91 billion and an adjusted EPS of $1.83 in the second quarter of 2024.

A look at CVS Health Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Cvs Health Corp seems to have a positive long-term outlook. With high scores in both Value and Dividend, investors may see potential for good returns and steady income. However, the company scores lower in Growth, Resilience, and Momentum, indicating some challenges in those areas that may need to be addressed for sustained success.

Cvs Health Corp is an integrated pharmacy health care provider with a strong focus on pharmacy benefit management services and retail pharmacy operations. Despite facing some challenges in growth and momentum, the company’s high scores in value and dividend suggest stability and potential for profitability in the long term. Investors may want to keep an eye on how the company addresses its growth and resilience factors to ensure continued success.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Amentum Holdings, Inc. (AMTM)

22.51 USD +1.02 (+4.75%) Volume: 2.8M

Discover the robust performance of Amentum Holdings, Inc.’s stock price, currently trading at 22.51 USD with a remarkable increase of +4.75% this trading session. With a strong trading volume of 2.8M and a year-to-date percentage change of +6.13%, AMTM’s stock continues to show promising growth potential in the market.

Latest developments on Amentum Holdings, Inc.

Today, Amentum Holdings, Inc. (NYSE:AMTM) stock price movement was influenced by key events leading up to its fluctuation. A. D. Beadell Investment Counsel Inc. purchased shares in the company, while analysts at Royal Bank of Canada started covering Amentum. The company recently won a $447 million contract with the Air Forces Central Command for global asset management. Despite this positive news, Amentum stock fell on both Wednesday and Tuesday, underperforming the market. The sector perform rating for Amentum shares reflects growth exposure and budget uncertainties, impacting the stock price movement today.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Delta Air Lines, Inc. (DAL)

66.95 USD +5.53 (+9.00%) Volume: 26.88M

Delta Air Lines, Inc.’s stock price has soared to $66.95, marking a significant +9.00% increase this trading session, with a robust trading volume of 26.88M shares. Year-to-date, DAL’s stock performance has also seen a positive uptrend, with an impressive +11.04% gain, underlining its strong market presence and investor confidence.

Latest developments on Delta Air Lines, Inc.

Delta Air Lines has experienced a series of events leading up to today’s stock price movements. Passengers were forced to evacuate a Delta flight in Atlanta after an aborted takeoff in snowy conditions. The airline’s CEO expressed optimism for 2025, predicting it to be the best financial year in Delta’s history. Delta also announced a five-week bonus worth $1.4 billion for its employees. Strong quarterly results set the stage for a successful year ahead, with the airline’s stock on the rise due to increased premium travel demand and positive financial outlook. Despite some challenges, such as flight cancellations and passenger injuries, Delta remains focused on innovation and partnerships to ensure continued growth and success.

A look at Delta Air Lines, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Delta Air Lines, Inc. provides scheduled air transportation for passengers, freight, and mail over a network of routes throughout the United States and internationally. Looking at the Smartkarma Smart Scores, Delta Air Lines has a strong outlook for growth and momentum, scoring 5 out of 5 in both categories. This indicates that the company is expected to experience significant growth and maintain strong momentum in the future, which bodes well for its long-term prospects.

However, Delta Air Lines scores lower in value, dividend, and resilience, with scores of 3, 2, and 2 respectively. This suggests that the company may not be as undervalued compared to its peers, may not offer a high dividend yield, and may have lower resilience to economic downturns. Despite these lower scores, the high marks in growth and momentum indicate that Delta Air Lines is well-positioned for future success and expansion in the airline industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Constellation Energy Corporation (CEG)

304.88 USD +61.03 (+25.03%) Volume: 13.97M

Constellation Energy Corporation’s stock price soars to $304.88, marking a significant trading session increase of +25.03%. With a robust trading volume of 13.97M and a year-to-date percentage change of +34.24%, CEG’s strong performance continues to attract investors.

Latest developments on Constellation Energy Corporation

Constellation Energy made headlines today with its blockbuster $16.4 billion deal to acquire Calpine, a move that would create one of the largest clean energy giants in America. The stock price soared as investors reacted positively to the news. This acquisition marks a significant step for Constellation Energy, joining forces with Calpine in a $26.6 billion deal to become a major player in the US power industry. The deal, fueled by AI technology, is set to create the largest US power generator, with a 60GW fleet. Constellation Energy’s stock price movements today reflect the market’s confidence in this strategic acquisition, propelling the company to new heights in the energy sector.

Constellation Energy Corporation on Smartkarma

Analysts at Baptista Research have been closely monitoring Constellation Energy Corporation’s performance, providing valuable insights into the company’s strategic initiatives and financial results. In their recent research reports, Baptista Research highlighted the company’s adaptation to electrification and data economy as key drivers for future growth. The analysts conducted an independent valuation of Constellation Energy using a Discounted Cash Flow methodology to evaluate potential price influences in the near future.

Constellation Energy Corporation’s recent earnings reports for different quarters have showcased a mix of challenges and strengths, according to Baptista Research. The company’s leadership, including President and CEO Joseph Dominguez and CFO Daniel Eggers, have been instrumental in driving operational performance and strategic progress. With a focus on future revenue streams from federal support and market dynamics, Baptista Research aims to provide investors with a comprehensive view of Constellation Energy’s current standing and growth potential.

A look at Constellation Energy Corporation Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Constellation Energy Corporation, a company focused on producing carbon-free energy and sustainable solutions, has received positive long-term outlook scores from Smartkarma. With a high Growth score of 5 and a Resilience score of 5, Constellation Energy is positioned well for future success. The company’s momentum score of 4 also indicates strong performance in the market, showcasing its ability to adapt and thrive in changing conditions.

While Constellation Energy’s Value and Dividend scores are slightly lower at 2, the overall outlook remains optimistic due to its strong Growth and Resilience scores. As a producer and distributor of nuclear, hydro, wind, and solar energy solutions, Constellation Energy serves a diverse range of customers in the United States, including homes, businesses, and public sectors. This broad reach, combined with its focus on sustainable energy, positions Constellation Energy well for continued success in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Walgreens Boots Alliance, Inc. (WBA)

11.76 USD +2.54 (+27.55%) Volume: 102.58M

Walgreens Boots Alliance, Inc.’s stock price is currently showing robust performance at 11.76 USD, with a remarkable trading session increase of +27.55% and a trading volume of 102.58M. The company’s stock has also exhibited a strong year-to-date (YTD) percentage change of +26.05%, highlighting its promising investment potential.

Latest developments on Walgreens Boots Alliance, Inc.

Walgreens Boots Alliance Inc. (WBA) has been making headlines with its recent earnings report, showing higher sales and surpassing estimates for the first quarter of fiscal 2025. The stock surged over 25% despite store closures, indicating investor optimism that the worst may be over for the company. CEO Tim Wentworth has garnered praise from Jim Cramer, expressing ‘tremendous faith’ in his leadership. With strong revenue growth and a better-than-expected performance, Walgreens Boots Alliance is signaling that its turnaround efforts are on track. The company’s stock price movements today reflect the positive sentiment surrounding its Q1 results, as it sticks to its annual profit forecast and shows resilience in the face of challenges.

Walgreens Boots Alliance, Inc. on Smartkarma

Analysts at Baptista Research on Smartkarma are closely monitoring Walgreens Boots Alliance (WBA) amid buyout discussions with Sycamore Partners, a private equity firm. The potential buyout news has caused a surge in Walgreens’ shares, signaling investor optimism. Despite facing challenges like margin pressures from pharmacy benefit managers and rising operating costs, the analysts believe that a strategic partnership could be beneficial for the struggling pharmacy giant.

In another report by Baptista Research on Smartkarma, analysts delve into Walgreens Boots Alliance Inc.’s Fourth Quarter FY 2024 results and strategic shifts. The company’s focus on capital discipline, store optimization, and cost-cutting measures has led to positive cash flow in the quarter. By evaluating various factors influencing the company’s stock price, including a Discounted Cash Flow methodology, analysts are optimistic about the potential turnaround for Walgreens Boots Alliance amidst ongoing operational improvements.

A look at Walgreens Boots Alliance, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Walgreens Boots Alliance, Inc. is positioned well for long-term success according to Smartkarma Smart Scores. With high scores in both Value and Dividend, the company is seen as a solid investment option for those looking for stability and potential returns. However, the lower scores in Growth and Resilience indicate some challenges that the company may face in terms of expanding its business and weathering economic uncertainties.

Despite these factors, Walgreens Boots Alliance shows promise with a strong Momentum score. This suggests that the company is currently on an upward trajectory and could continue to see positive performance in the near future. Overall, with its diverse range of offerings including retail drugstores, health services, and wellness programs, Walgreens Boots Alliance remains a key player in the healthcare industry.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma

Biggest stock gainers today in S&P 500

Biggest stock losers today in S&P 500

What is Smartkarma SmartScore?

It is a compound score for a Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores (Value, Dividend, Growth, Resilience, Momentum scores) computed by Smartkarma.

The best stock screener – Smartkarma SmartScore Screener

Smartkarma’s stock screener, Smartkarma SmartScore Screener, allows you to easily discover undervalued gems, high dividend stocks, and high growth stocks, across multiple countries and sectors.

Explore the Smartkarma SmartScore Screener now.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma